NYSE · SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH · LARGE CAP
Iqvia Holdings Inc. IQV
15 fiscal years on record · USD · FY2025 reported
SEC FILINGS ONLY
Revenue · FY2025
$16.3B
▲ 5.9% vs FY2024
EPS · FY25
$7.84
Dividend / sh · FY25
—
Payout · FY25
—
ROE · FY25
21.6%
Net margin · FY25
8.3%
Dividend coverage
—
Advertisement
AdSense · Leaderboard 728×90320×100
Result
USD 16.3B
Revenue, FY2025 · full 15-year series below
Revenue
Net income
8 cents of every revenue dollar became profit this year.
Per share
USD 7.84
Diluted EPS, FY2025
EPS
The company pays no cash dividend.
Profitability
21.6%
Return on equity, FY2025
ROE
Operating margin13.4%
Net margin8.3%
Return on assets4.8%
Each USD of equity produced 22 cents of profit this year.
Returned to shareholders
USD 1.2B
returned in FY2025 · dividends + net buybacks
Dividends paid—
Net buybacksUSD 1.2B
Share of profit91.5%
Consecutive raises—
USD 1.2B in buybacks — 91% of the year's profit went back to shareholders.
Growth
+7.5% a year
revenue, compounded over five years
CAGR
3 yrs
5 yrs
10 yrs
15 yrs
Revenue
+4.2%
+7.5%
+11.0%
Net income
+7.6%
+37.3%
+13.4%
EPS, diluted
+11.1%
+40.5%
Returned to shareholders
+2.1%
+22.7%
+9.2%
Compound annual rates per period — left blank where the series crosses a loss.
Share base
0.17B
Shares outstanding, FY2025
Change, 5 years−11.3%
Change, 10 years—
The share count shrank 11% in five years — the same company, cut into fewer, larger slices.
Advertisement
AdSense · Leaderboard 728×90300×250
Balance sheet
USD 29.9B
total assets, end of FY2025
Total assetsUSD 29.9B
EquityUSD 6.5B
CashUSD 2.0B
Gross debtUSD 15.7B
Net debtUSD 13.7B
Current ratio0.75×
Net debt stands at 211% of equity.
History
15 fiscal years
Every figure from documents filed with the SEC · USD
Metric
2025
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
Revenue $B
16.3
15.4
15.0
14.4
13.9
11.4
11.1
10.4
9.7
6.8
5.7
5.5
5.1
4.9
4.3
Operating income $B
2.2
2.2
2.0
1.8
1.4
0.7
0.8
0.7
0.7
0.6
0.6
0.6
0.5
0.4
0.3
EBITDA $B
3.3
3.3
3.1
2.9
2.7
2.0
2.0
1.9
1.7
0.9
0.8
0.7
0.6
0.5
0.4
Income tax $B
0.3
0.3
0.1
0.3
0.2
0.1
0.1
0.1
−1.0
0.3
0.2
0.1
0.1
0.1
0.0
Net income $B
1.4
1.4
1.4
1.1
1.0
0.3
0.2
0.3
1.3
0.1
0.4
0.4
0.2
0.2
0.2
EPS, diluted $
7.84
7.49
7.29
5.72
4.95
1.43
0.96
1.24
5.74
0.47
3.08
2.72
1.77
1.51
2.05
Dividend / sh $
·
·
·
·
·
·
·
·
·
·
·
·
·
·
·
Payout %
·
·
·
·
·
·
·
·
·
·
·
·
·
320
119
ROE %
21.6
22.6
·
18.1
16.0
4.6
3.0
3.5
15.4
1.8
·
·
·
·
·
Shares out B
0.17
0.18
0.18
0.19
0.19
0.19
0.19
0.20
·
0.25
0.12
0.12
0.13
0.12
0.12
Slide the table for earlier years · "·" marks figures not disclosed in the filing for that year.
How we verifyAUDITED
43 of 43
checks passed before publication
EPS recomputationBalance-sheet identityGross profitBalance-sheet liquidity
Every figure was compared against the original statement: 0 failures and 0 presentation gaps.
What we don’t show
We’d rather say what’s missing than fill the gap with an estimate.
P/E rationeeds a market quote — not yet licensed
Market capitalizationneeds a market quote — not yet licensed
Dividend yieldneeds a market quote — not yet licensed
Price-to-bookneeds a market quote — not yet licensed